Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This commentary discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edinburgh.

More information Original publication

DOI

https://doi.org/10.1186/s13195-017-0312-4

Type

Journal article

Publication Date

2017

Volume

9

Keywords

Dementia Alzheimer’s disease Therapeutics Disease-modification Service redesign Clinical trials